SCHEMBL723123

SCHEMBL723123

CCCSCCC(O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.52
FFAR1 O14842 1/20 0.52
TET2 Q6N021 3/20 0.43
KDM4A O75164 2/20 0.43
KDM4C Q9H3R0 2/20 0.43
KDM2A Q9Y2K7 2/20 0.43
TET3 O43151 1/20 0.43
BHMT Q93088 6/20 0.40
BHMT2 Q9H2M3 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
CHRM1 P11229 1/20 0.39
AKR1A1 P14550 1/20 0.39
CHRM3 P20309 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
ADRA1A P35348 1/20 0.39
HRH1 P35367 1/20 0.39
DRD3 P35462 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HDAC1 Q13547 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4951710 0.88 GPR84 (0.59) GPR84FFAR1TET2KDM4AKDM4C
SCHEMBL9937927 0.88 GPR84 (0.59) GPR84FFAR1TET2KDM4AKDM4C
SCHEMBL721101 0.86 GPR84 (0.50) GPR84FFAR1TET2KDM4AKDM4C
SCHEMBL722785 0.86 GPR84 (0.62) GPR84FFAR1TET2KDM4AKDM4C
SCHEMBL18832143 0.86 GPR84 (0.62) GPR84FFAR1BHMT
SCHEMBL18832138 0.84 GPR84 (0.66) GPR84FFAR1BHMT
SCHEMBL18832145 0.84 GPR84 (0.66) GPR84FFAR1BHMT
SCHEMBL18832149 0.84 GPR84 (0.66) GPR84FFAR1BHMT
SCHEMBL4953619 0.82 BHMT (0.42) GPR84BHMTBHMT2TDP1CHRM1
SCHEMBL7446893 0.80 GPR84 (0.43) GPR84FFAR1TET2KDM4AKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106795511-B Oxidase, polynucleotide encoding the same, and use thereof 住友化学株式会社 2020-02-11 CN disclosed
CN-106661571-B Oxidase, polynucleotide encoding the same, and use thereof 住友化学株式会社 2019-12-20 CN disclosed
EP-3168301-B1 OXIDASE, POLYNUCLEOTIDE ENCODING SAME, AND USE OF THESE SUMITOMO CHEMICAL CO (JP) 2019-11-20 EP disclosed
US-10364448-B2 Method for producing L-α-amino acid compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-07-30 US disclosed
US-10351829-B2 Oxidase, polynucleotide that codes for same, and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-07-16 US disclosed
US-20170191097-A1 OXIDASE, POLYNUCLEOTIDE ENCODING SAME, AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-07-06 US disclosed
US-20170159029-A1 OXIDASE, POLYNUCLEOTIDE THAT CODES FOR SAME, AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-06-08 US disclosed
EP-3168301-A1 OXIDASE, POLYNUCLEOTIDE ENCODING SAME, AND USE OF THESE Sumitomo Chemical Company, Limited (JP) 2017-05-17 EP disclosed
EP-3168302-A1 OXIDASE, POLYNUCLEOTIDE THAT CODES FOR SAME, AND USES FOR BOTH Sumitomo Chemical Company, Limited (JP) 2017-05-17 EP disclosed
EP-2609077-A1 PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND Sumitomo Chemical Company Limited (JP) 2013-07-03 EP disclosed
WO-2012081712-A1 PROCESS FOR THE PREPARATION OF HYDROXYCARBOXYLIC ACID COMPOUND OR SALT THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-06-21 WO disclosed
WO-2012026620-A1 PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-01 WO disclosed
WO-2012026619-A1 PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-01 WO disclosed
US-7465471-B2 Palatability of aquaculture feed NOVUS INTERNATIONAL, INC. (US) 2008-12-16 US disclosed
WO-2007147155-A1 POLYOL ESTER COMPOUNDS NOVUS INTERNATIONAL INC. (US) 2007-12-21 WO disclosed
US-20070292485-A1 POLYOL ESTER COMPOUNDS NOVUS INTERNATIONAL INC. (US) 2007-12-20 US disclosed
US-20050215623-A1 Palatability of aquaculture feed NOVUS INTERNATIONAL, INC. (US) 2005-09-29 US disclosed
EP-1531672-A2 ANTIMICROBIAL COMPOSITIONS Novus International, Inc. (US) 2005-05-25 EP disclosed
US-20040175434-A1 Antimicrobial compositions NOVUS INTERNATIONAL, INC. 2004-09-09 US disclosed
WO-2004019683-A2 ANTIMICROBIAL COMPOSITIONS NOVUS INTERNATIONAL, INC. (US) 2004-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070292485-A1 POLYOL ESTER COMPOUNDS PNLIP, ELOVL1, ELOVL5 GPR84 1794/4885FFAR1 204/4885TET2 1911/4885
US-10351829-B2 Oxidase, polynucleotide that codes for same, and use thereof DAO, PNPO, HAO1 GPR84 4093/4885FFAR1 2509/4885TET2 83/4885
US-20050215623-A1 Palatability of aquaculture feed TAS2R3, TAS2R1, TAS2R20 GPR84 893/4885FFAR1 747/4885TET2 3697/4885
US-20040175434-A1 Antimicrobial compositions MRPL21, FPR1, ARG1 GPR84 4587/4885FFAR1 2240/4885TET2 3663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.